INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 136 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q2 2021. The put-call ratio across all filers is 0.94 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $167,000 | -27.4% | 11,090 | 0.0% | 0.00% | -100.0% |
| Q2 2021 | $230,000 | -7.3% | 11,090 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $248,000 | -8.1% | 11,090 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $270,000 | -40.9% | 11,090 | 0.0% | 0.00% | -50.0% |
| Q3 2020 | $457,000 | -49.9% | 11,090 | -22.1% | 0.00% | -66.7% |
| Q3 2019 | $913,000 | -60.9% | 14,240 | -51.5% | 0.01% | -50.0% |
| Q2 2019 | $2,333,000 | +165.7% | 29,380 | +267.7% | 0.01% | +140.0% |
| Q1 2019 | $878,000 | -35.8% | 7,990 | -45.6% | 0.01% | -44.4% |
| Q4 2018 | $1,367,000 | +55.7% | 14,690 | +83.9% | 0.01% | +80.0% |
| Q3 2018 | $878,000 | +34.3% | 7,990 | -2.4% | 0.01% | +25.0% |
| Q2 2018 | $654,000 | +32.7% | 8,190 | 0.0% | 0.00% | +33.3% |
| Q1 2018 | $493,000 | -44.3% | 8,190 | -2.4% | 0.00% | -57.1% |
| Q4 2017 | $885,000 | 0.0% | 8,390 | 0.0% | 0.01% | 0.0% |
| Q3 2017 | $885,000 | -14.1% | 8,390 | 0.0% | 0.01% | -12.5% |
| Q2 2017 | $1,030,000 | +8.8% | 8,390 | 0.0% | 0.01% | -11.1% |
| Q1 2017 | $947,000 | +222.1% | 8,390 | +223.9% | 0.01% | +200.0% |
| Q4 2016 | $294,000 | -23.2% | 2,590 | +8.4% | 0.00% | -25.0% |
| Q3 2016 | $383,000 | +7.0% | 2,390 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $358,000 | -72.7% | 2,390 | -77.2% | 0.00% | -73.3% |
| Q1 2016 | $1,309,000 | -29.1% | 10,470 | -14.9% | 0.02% | -28.6% |
| Q4 2015 | $1,847,000 | -8.1% | 12,310 | +1.7% | 0.02% | -16.0% |
| Q3 2015 | $2,009,000 | -23.7% | 12,110 | +11.0% | 0.02% | -19.4% |
| Q2 2015 | $2,633,000 | -11.2% | 10,910 | +3.8% | 0.03% | -16.2% |
| Q1 2015 | $2,964,000 | – | 10,510 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 635,300 | $39,083,000 | 9.04% |
| Senvest Management, LLC | 1,152,032 | $70,873,000 | 5.40% |
| Melqart Asset Management (UK) Ltd | 298,200 | $18,345,000 | 2.20% |
| Elk Creek Partners, LLC | 348,454 | $21,437,000 | 1.25% |
| ALTRINSIC GLOBAL ADVISORS LLC | 375,223 | $23,084,000 | 0.93% |
| BB BIOTECH AG | 545,719 | $33,573,000 | 0.93% |
| Virtus ETF Advisers LLC | 14,681 | $903,000 | 0.78% |
| Opus Point Partners Management, LLC | 4,496 | $277,000 | 0.54% |
| Spark Investment Management LLC | 136,500 | $8,397,000 | 0.54% |
| Regal Investment Advisors LLC | 29,511 | $1,816,000 | 0.40% |